October
Industry Briefs October 2016
Controversy Surrounding Mylan’s EpiPen Heather Bresch, CEO of Mylan, testified before the U.S. House ...
Unforgettable: The 8th Annual Trailblazer Awards Gala
The evening of September 23rd was a quite a beautiful, memorable night as PM360 ...
4 Ways Pharmaceutical Reps Can Unlock the Power of EHRs
Electronic health records (EHRs), now used by 83% of office-based physicians1 present both opportunities ...
Healthcare Watch October 2016
Doctor Docs: The U.S. Calls for More Public Info In conjunction with the UN’s ...
Surviving the Shift to Bundled Payments
Whether we like it or not, bundled payments are here. With this shift comes ...
The Stars for Healthcare Partnerships are Aligning!
It doesn’t take a marketing and sales genius to know that your bottom line ...
We Interrupt this Program
“Advertisements now are so numerous that they are very negligently perused.” 2016? Not even ...
Specialty Pharmacies: A Growing Channel for Better Patient Outcomes
The American Pharmacists’ Association notes that “with specialty-trained pharmacists as part of the collaborative ...
Remembering the Humanity in What We Do
Many of us were drawn to the healthcare industry because of the potential to ...
The 3D Revolution
3D printing is perhaps one of the most revolutionary breakthroughs in science and technology. ...
Movers and Shakers October 2016
Finn Partners Adds New Senior Counsel One of the most skilled storytellers in the ...
My Other Life with Steve Zlotnick
PM360 recently spoke to Steve Zlotnick, PharmD, Principal Medical Science Liaison, Immunology at Genentech, ...
